Insulet
PODD
812 hedge funds and large institutions have $21.1B invested in Insulet in 2025 Q3 according to their latest regulatory filings, with 108 funds opening new positions, 339 increasing their positions, 243 reducing their positions, and 82 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 339 | Existing positions reduced: 243
32% more first-time investments, than exits
New positions opened: 108 | Existing positions closed: 82
2% more funds holding
Funds holding: 795 → 812 (+17)
4% less capital invested
Capital invested by funds: $22B → $21.1B (-$935M)
2.6% less ownership
Funds ownership: 99.62% → 97.02% (-2.6%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
48% less call options, than puts
Call options by funds: $98.5M | Put options by funds: $191M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
+$70.6M |
| 2 |
MP
Munro Partners
Melbourne,
Australia
|
+$66.7M |
| 3 |
BlackRock
New York
|
+$55.8M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$48.9M |
| 5 |
Parnassus Investments
San Francisco,
California
|
+$47.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$131M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$109M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
-$90.7M |
| 4 |
Goldman Sachs
New York
|
-$72.4M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$58.6M |
PODD Hedge Fund Activity: Q3 2025 in Review
812 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q3 2025, worth a combined $21.1B — down 4.2% from $22B a quarter earlier.
Buyers outnumbered sellers: 108 funds opened new PODD positions and 82 closed out — a net gain of 26 holders — while 339 added to existing stakes and 243 trimmed.
The largest buyer was Squarepoint, adding an estimated $70.6M. The largest seller was Citadel Advisors, cutting an estimated $131M.
- 812 institutional investors held Insulet (PODD) as of Q3 2025, up from 795 in Q2 2025.
- Funds reported $21.1B of Insulet stock for Q3 2025, down 4.2% quarter-over-quarter.
- 108 funds opened new Insulet positions in Q3 2025 and 82 closed out, a net change of +26 holders.
- The largest Insulet buyer in Q3 2025 was Squarepoint, an estimated $70.6M added.
- The largest Insulet seller in Q3 2025 was Citadel Advisors, an estimated $131M sold.
Based on aggregated 13F filings for Q3 2025.